Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

D Mendes, J Abrantes, G Rigueiro… - Journal of Oncology …, 2021 - journals.sagepub.com
Purpose The aim of this study was to assess the safety profiles of two biosimilar medicines
(rituximab and trastuzumab) in the treatment of cancer patients within a Portuguese …
被引用次数：7 相关文章

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital.

D Mendes, J Abrantes, G Rigueiro… - Journal of Oncology …, 2021 - search.ebscohost.com
Purpose: The aim of this study was to assess the safety profiles of two biosimilar medicines
(rituximab and trastuzumab) in the treatment of cancer patients within a Portuguese …

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital.

D Mendes, J Abrantes, G Rigueiro, AF Pais… - Journal of Oncology …, 2020 - europepmc.org
Purpose The aim of this study was to assess the safety profiles of two biosimilar medicines
(rituximab and trastuzumab) in the treatment of cancer patients within a Portuguese …

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

D Mendes, J Abrantes, G Rigueiro… - … publication of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose The aim of this study was to assess the safety profiles of two biosimilar medicines
(rituximab and trastuzumab) in the treatment of cancer patients within a Portuguese …